The fatty acid content and drug binding characteristics of commercial albumin preparations

Donald J. Birkett, Shirley P. Myers, Gillian Sudlow

Research output: Contribution to journalArticlepeer-review

31 Citations (Scopus)

Abstract

The fatty acid contents of thirteen commercial preparations of human albumin were found to be in the range 0.03 to 9 mol of fatty acid/mol albumin. Marked differences were found between the preparations in the binding of the fluorescent probes, 5-dimethylamino-naphthalene-1-sulfonamide (DNSA) and dansylsarcosine. The displacement of these probes by ibuprofen and phenylbutazone also showed marked differences between preparations. The differences between the commercial albumin samples correlated well with their fatty acid contents and were abolished by treatment with charcoal. They were similar to the changes observed when oleic acid was added to fatty acid free albumin. The source and fatty acid content of commercial albumin preparations should be considered when comparing studies of the binding of drugs to human albumin.

Original languageEnglish
Pages (from-to)253-258
Number of pages6
JournalClinica Chimica Acta
Volume85
Issue number3
DOIs
Publication statusPublished - 2 May 1978
Externally publishedYes

Fingerprint Dive into the research topics of 'The fatty acid content and drug binding characteristics of commercial albumin preparations'. Together they form a unique fingerprint.

Cite this